Discover Anagram's Imaging CoreLab

Research on stroke treatment is crucial due to its profound impact on public health, being a leading cause of disability and death. Effective therapies are essential to enhance recovery rates and reduce long-term care costs. In this vital context, BHH member Anagram's Imaging CoreLab plays an indispensable role in advancing clinical trials for stroke treatments through precision and innovation. 

With over 25 years of experience within Anagram CRO, the CoreLab improves the accuracy and efficiency of stroke clinical trials by utilizing advanced technology and meticulous processes. It ensures that imaging data meets the highest standards of reliability and regulatory compliance, which is essential for the success of clinical trials.

Anagram's sophisticated software platform supports this mission by offering secure, compliant, and user-friendly tools for image analysis, data management, and stakeholder communication. The platform ensures seamless traceability and data integrity, facilitating comprehensive reporting and rapid diagnosis. Moreover, strong internal communication between CRAs and the CoreLab further enhances data integrity. This collaboration allows for prompt resolution of discrepancies and smooth operation throughout the trial process. The CoreLab's rigorous quality control processes verify and standardize image evaluations, bolstering the reliability of clinical trial data.

Overall, Anagram's Imaging CoreLab exemplifies the critical importance of precision in clinical trials. Its commitment to excellence and innovation significantly advances medical research and improves patient outcomes, especially in the crucial area of stroke treatment.

Discover more about Anagram's Imaging CoreLab HERE.